As
the spread of infections caused by hepatitis B virus (HBV) threatens
public health worldwide, investigations from multiple perspectives
and of various mechanisms of action are urgently required to increase
the HBV cure rate. Targeting the encapsidation of the nuclear capsid
protein (core protein, HBc) has emerged as an attractive strategy
for inhibiting the viral assembly process; however, a drug targeting
this mechanism has not yet been approved. We synthesized novel sulfamoylbenzamides
(SBAs) as capsid assembly modulators of HBV and found that the effects
and safety profiles of compounds 3 and 8 have potential therapeutic applicability against HBV. The formation
of tubular particles was time-dependent in the presence of 3, indicating a new mode of protein assembly by SBA compounds. Our
findings provide a new entity for developing safe and efficient treatments
for HBV infection.
Gemcitabine is a
nucleoside analogue of deoxycytidine and has been
reported to be a broad-spectrum antiviral agent against both DNA and
RNA viruses. Screening of a nucleos(t)ide analogue-focused library
identified gemcitabine and its derivatives (compounds 1, 2a, and 3a) blocking influenza virus
infection. To improve their antiviral selectivity by reducing cytotoxicity,
14 additional derivatives were synthesized in which the pyridine rings
of 2a and 3a were chemically modified. Structure-and-activity
and structure-and-toxicity relationship studies demonstrated that
compounds 2e and 2h were most potent against
influenza A and B viruses but minimally cytotoxic. It is noteworthy
that in contrast to cytotoxic gemcitabine, they inhibited viral infection
with 90% effective concentrations of 14.5–34.3 and 11.4–15.9
μM, respectively, maintaining viability of mock-infected cells
over 90% at 300 μM. Resulting antiviral selectivity was comparable
to that of a clinically approved nucleoside analogue, favipiravir.
The cell-based viral polymerase assay proved the mode-of-action of 2e and 2h targeting viral RNA replication and/or
transcription. In a murine influenza A virus-infection model, intraperitoneal
administration of 2h not only reduced viral RNA level
in the lungs but also alleviated infection-mediated pulmonary infiltrates.
In addition, it inhibited replication of severe acute respiratory
syndrome virus 2 infection in human lung cells at subtoxic concentrations.
The present study could provide a medicinal chemistry framework for
the synthesis of a new class of viral polymerase inhibitors.
Numerous disinfection methods have been developed to
reduce the
transmission of infectious diseases that threaten human health. However,
it still remains elusively challenging to develop eco-friendly and
cost-effective methods that deactivate a wide range of pathogens,
from viruses to bacteria and fungi, without doing any harm to humans
or the environment. Herein we report a natural spraying protocol,
based on a water-dispersible supramolecular sol of nature-derived
tannic acid (TA) and Fe3+, which is easy-to-use and low-cost.
Our formulation effectively deactivates viruses (influenza A viruses,
SARS-CoV-2, and human rhinovirus) as well as suppressing the growth
and spread of pathogenic bacteria (Escherichia coli, Salmonella typhimurium, Staphylococcus aureus, and Acinetobacter
baumannii) and fungi (Pleurotus ostreatus and Trichophyton rubrum). Its versatile applicability
in a real-life setting is also demonstrated against microorganisms
present on the surfaces of common household items (e.g., air filter
membranes, disposable face masks, kitchen sinks, mobile phones, refrigerators,
and toilet seats).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.